Reify Health

Empowering the Clinical Trials Ecosystem

Boston, United States · Founded 2012 · $477.5M raised

Employees
501–1000
Founded
2012
Business Model
B2B
Total Funding
$477.5M
Last Round
$220.0M Series DApr 2022
Rounds
4

About

Reify Health is a Boston-based clinical trial technology company on a mission to remove clinical trial operations as the bottleneck on delivering new therapies to patients. Through its two business entities — OneStudyTeam (trial optimization software) and Care Access (clinical trial infrastructure expanding access to underserved communities) — Reify Health provides end-to-end solutions for the clinical trial ecosystem. The company's StudyTeam platform has been adopted by major biopharma companies including Amgen. Founded in 2012, Reify Health is valued at approximately $4.8 billion.

Summary

Reify Health is a Healthcare company based in Boston, United States, founded in 2012. It has raised $477.5M in total across 4 rounds, most recently a $220.0M Series D round in Apr 2022. Investors include Altimeter Capital, Dragoneer and Coatue Management.

Tech & App Stack

7 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series DSeries DApr 2022
$220.0M

Sign up to see all 4 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies